Pharmaceutical Segment is the largest segment driving the growth of the Rivastigmine Market
Rivastigmine is a reversible cholinesterase inhibitor used for the treatment of mild to moderate dementia associated with Parkinson’s disease. It works by inhibiting the breakdown …